IgG1 anti-EGFR antibody binds EGFR on tumor cells and engages FcγR-bearing effector cells (e.g., NK cells) to mediate ADCC (and possibly CDC); EGFR signaling blockade is mainly cytostatic but can contribute to apoptosis.